A new market study, titled “Hydroxychloroquine Market Forecast 2021-2028” has been featured on Fortune Business Insights™.
***Get Latest Updated Market Research Report with Free Sample Report
According to a report published by Fortune business Insights, titled “Hydroxychloroquine Market Size, Share & Industry Analysis, By Disease Indication (Malaria, COVID-19, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2021-2028,” the market was worth USD 894.0 million in 2020 and will exhibit a CAGR of 5.5% during the forecast period, 2021-2028.
Request for Free Sample Report PDF @ www.fortunebusinessinsights.com/enquiry/sample/hydroxychloroquine-market-102706
Increasing Efforts Taken to Maximize the Production Will Aid Market Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. The ability of hydroxychloroquine to speed up recovery processes in the treatment of patients suffering from diseases such as malaria and rheumatoid arthritis has contributed to the growing demand for the product. The increasing product demand has encouraged several companies to enhance their production methods as well as capabilities associated with the product. The report labels several companies that have taken several steps to increase the production of hydroxychloroquine during the coronavirus pandemic. In April 2020, Zydus Caadila announced that it has scaled up the production of hydroxychloroquine. The company was encouraged by the sudden rise in the demand for the product; a factor that was consequential to the constantly rising Covid-19 cases across the world. Zydus’ latest step will have a huge impact on the growth of the overall market in the coming years.
The Asia Pacific Likely to Emerge Dominant; Increasing Production of Hydroxychloroquine Will Aid Market Growth
The report analyzes the ongoing market trends across North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. Among these regions, the market in Asia Pacific is likely to emerge leading. The high production of the product in several countries across this region will aid the growth of the regional market. India is currently the largest producer of hydroxychloroquine, with over 70% of the global production occurring in the country. As of 2019, the market in Asia Pacific was worth USD 346.9 million and this value is projected to increase further in the coming years. Besides Asia Pacific, the market in North America will also witness considerable growth due to the increasing incidences of coronavirus in the United States.
Özelleştirme isteyin @ www.fortunebusinessinsights.com/enquiry/customization/hidroksiklorokin-market-102706
Profili açılan şirketlerin listesi
- Zydus Cadia
- İpca Laboratuvarları Ltd.
- Sandoz International GmbH (Novartis AG’nin bir parçası)
- Mylan NV
- Teva İlaç Sanayii Ltd.
- Bayer AG
- Rapordaki diğerleri:
Mart 2020: Mylan NV, ABD’de COVID-19’un ilerlemesini kontrol etmek için Batı Virjinya tesisindeki hidroksiklorokin üretim kapasitesini artıracağını duyurdu
Devam etti. . .
NOT: Ekibimiz Covid19’u ve bunun çeşitli sektör dikeyleri üzerindeki etkisini inceliyor ve gerektiğinde daha iyi pazar ve sektör analizi için covid19 ayak izlerini dikkate alacağız. Daha fazla ayrıntı için içtenlikle iletişime geçin.
Fortune Business Insights™ doğru veriler ve yenilikçi kurumsal analizler sunarak her büyüklükteki kuruluşun uygun kararlar almasına yardımcı olur. Müşterilerimiz için özgün çözümler üreterek, işlerine özgü çeşitli zorlukların üstesinden gelmelerine yardımcı oluyoruz. Faaliyet gösterdikleri pazara ayrıntılı bir genel bakış sağlayarak onları bütünsel pazar istihbaratıyla güçlendirmeyi amaçlıyoruz.
Bizimle iletişime geçin:
Fortune Business Insights™ Pvt. Ltd.
308, Yüksek Karargah,
Anket No. 36, Baner,
Pune – 411045, Maharashtra, Hindistan.
ABD :+1 424 253 0390
İngiltere : +44 2071 939123
APAC : +91 744 740 1245
E-posta: [email protected]